21st Mar 2007 07:00
GlaxoSmithKline PLC20 March 2007 This is a repeat transmission of the announcement originally made at 17:32 on 20March 2007 to correct the number of shares held in Treasury and the number ofshares in issue (excluding Treasury shares). All other details remain unchanged.The RNS number of the original announcement is 3596T. GlaxoSmithKline plc (the "Company") announces that in accordance with theauthority granted by shareholders at the Company's Annual General Meeting on 17May 2006 it purchased 500,000 of its Ordinary shares of 25 pence each ("shares")on 20 March 2007 at a price of 1400.62 pence per share. The Company intends to hold these shares in Treasury. Following the purchase of these shares, the Company holds 265,582,678 of itsshares in Treasury. The Company has 5,744,104,759 shares in issue (excluding Treasury shares). Thisnumber represents the total voting rights in the Company and may be used byshareholders as the denominator for the calculations by which they can determineif they are required to notify their interest in, or a change to their interestin the Company under the Financial Services Authority's Disclosure andTransparency Rules. This announcement does not constitute, or form part of, an offer or anysolicitation of an offer to purchase or subscribe for securities in anyjurisdiction and is in conformity with the Transparency Directive's transitionalprovision 6. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline